BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 31571723)

  • 1. Effectiveness of a commercial porcine reproductive and respiratory syndrome virus (PRRSV) subunit vaccine against heterologous PRRSV-1 and PRRSV-2 challenge in late-term pregnant gilts.
    Oh T; Kim H; Park KH; Jeong J; Kang I; Yang S; Chae C
    Can J Vet Res; 2019 Oct; 83(4):248-254. PubMed ID: 31571723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A modified-live porcine reproductive and respiratory syndrome virus (PRRSV)-1 vaccine protects late-term pregnancy gilts against heterologous PRRSV-1 but not PRRSV-2 challenge.
    Jeong J; Kang I; Kim S; Park SJ; Park KH; Oh T; Yang S; Chae C
    Transbound Emerg Dis; 2018 Oct; 65(5):1227-1234. PubMed ID: 29536637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A modified-live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine protects late-term pregnancy gilts against a heterologous PRRSV-2 challenge.
    Yang S; Kang I; Cho H; Oh T; Park KH; Min KD; Chae C
    Can J Vet Res; 2020 Jul; 84(3):172-180. PubMed ID: 32801451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-protection of a modified-live porcine reproductive and respiratory syndrome virus (PRRSV)-2 vaccine against a heterologous PRRSV-1 challenge in late-term pregnancy gilts.
    Jeong J; Park C; Oh T; Park KH; Yang S; Kang I; Park SJ; Chae C
    Vet Microbiol; 2018 Sep; 223():119-125. PubMed ID: 30173737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of commercial modified-live PRRSV-1 and PRRSV-2 vaccines against a dual heterologous PRRSV-1 and PRRSV-2 challenge in late term pregnancy gilts.
    Yang S; Oh T; Cho H; Chae C
    Comp Immunol Microbiol Infect Dis; 2020 Apr; 69():101423. PubMed ID: 31972500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of a novel inactivated PRRS virus vaccine on virus replication and virus-induced pathology in fetal implantation sites and fetuses upon challenge.
    Karniychuk UU; Saha D; Vanhee M; Geldhof M; Cornillie P; Caij AB; De Regge N; Nauwynck HJ
    Theriogenology; 2012 Oct; 78(7):1527-37. PubMed ID: 22980086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of concurrent vaccination with modified-live PRRSV-1 and PRRSV-2 vaccines against heterologous dual PRRSV-1 and PRRSV-2 challenge in late term pregnancy gilts.
    Yang S; Oh T; Kang I; Park SJ; Chae C
    Vet Microbiol; 2019 Dec; 239():108497. PubMed ID: 31767085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of an inactivated vaccine against porcine reproductive and respiratory syndrome to protect gilts against a heterologous challenge with PRRSV.
    Scortti M; Prieto C; Alvarez E; Simarro I; Castro JM
    Vet Rec; 2007 Dec; 161(24):809-13. PubMed ID: 18083979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproductive performance of gilts following vaccination and subsequent heterologous challenge with European strains of porcine reproductive and respiratory syndrome virus.
    Scortti M; Prieto C; Simarro I; Castro JM
    Theriogenology; 2006 Nov; 66(8):1884-93. PubMed ID: 16806451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reproductive, productivity, and mortality outcomes in late-gestation gilts and their litters following simulation of inadvertent exposure to a modified-live vaccine strain of porcine reproductive and respiratory syndrome (PRRS) virus.
    Schelkopf A; Nerem J; Cowles B; Amodie D; Swalla R; Dee S
    Vaccine; 2014 Aug; 32(36):4639-43. PubMed ID: 24975816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the new commercial recombinant chimeric subunit vaccine PRRSFREE in challenge with heterologous types 1 and 2 porcine reproductive and respiratory syndrome virus.
    Jeong J; Park C; Choi K; Chae C
    Can J Vet Res; 2017 Jan; 81(1):12-21. PubMed ID: 28154457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the severity of reproductive failure between single and dual infection with porcine reproductive and respiratory syndrome virus (PRRSV)-1 and PRRSV-2 in late-term pregnancy gilts.
    Jeong J; Kang I; Park C; Kim S; Park SJ; Park KH; Oh T; Yang S; Yoon JS; Lee O; Chae C
    Transbound Emerg Dis; 2018 Dec; 65(6):1641-1647. PubMed ID: 29877065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of a novel European vaccine for porcine reproductive and respiratory virus in bred gilts.
    Piontkowski MD; Kroll J; Orveillon FX; Kraft C; Coll T
    Can J Vet Res; 2016 Oct; 80(4):269-280. PubMed ID: 27733781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Commercial porcine reproductive and respiratory syndrome virus (PRRSV)-2 modified live virus vaccine against heterologous single and dual Korean PRRSV-1 and PRRSV-2 challenge.
    Jeong J; Kim S; Park C; Park KH; Kang I; Park SJ; Chae C
    Vet Rec; 2018 Apr; 182(17):485. PubMed ID: 29472439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of two genetically distant type 2 porcine reproductive and respiratory syndrome virus (PRRSV) modified live vaccines against Vietnamese highly pathogenic PRRSV.
    Do DT; Park C; Choi K; Jeong J; Nguyen TT; Nguyen KD; Vo DT; Chae C
    Vet Microbiol; 2015 Sep; 179(3-4):233-41. PubMed ID: 26149103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody response and maternal immunity upon boosting PRRSV-immune sows with experimental farm-specific and commercial PRRSV vaccines.
    Geldhof MF; Van Breedam W; De Jong E; Lopez Rodriguez A; Karniychuk UU; Vanhee M; Van Doorsselaere J; Maes D; Nauwynck HJ
    Vet Microbiol; 2013 Dec; 167(3-4):260-71. PubMed ID: 24041768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative virulence of reproductive diseases caused by type 1 (European-like) and type 2 (North American-like) porcine reproductive and respiratory syndrome virus in experimentally infected pregnant gilts.
    Han K; Seo HW; Park C; Kang I; Youn SK; Lee SY; Kim SH; Chae C
    J Comp Pathol; 2014; 150(2-3):297-305. PubMed ID: 24447572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of commercial genotype 1 porcine reproductive and respiratory syndrome virus (PRRSV) vaccine against field isolate of genotype 2 PRRSV.
    Ko SS; Seo SW; Sunwoo SY; Yoo SJ; Kim MH; Lyoo YS
    Vet Immunol Immunopathol; 2016 Apr; 172():43-9. PubMed ID: 27032502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-protection of a new type 2 porcine reproductive and respiratory syndrome virus (PRRSV) modified live vaccine (Fostera PRRS) against heterologous type 1 PRRSV challenge in growing pigs.
    Park C; Choi K; Jeong J; Chae C
    Vet Microbiol; 2015 May; 177(1-2):87-94. PubMed ID: 25769646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strain predominance following exposure of vaccinated and naive pregnant gilts to multiple strains of porcine reproductive and respiratory syndrome virus.
    Lager KM; Mengeling WL; Wesley RD
    Can J Vet Res; 2003 May; 67(2):121-7. PubMed ID: 12760477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.